Home Compliance Regeneron Pharmaceuticals FCA Case Put on Hold ComplianceFCANews Regeneron Pharmaceuticals FCA Case Put on Hold November 29, 2023 29 Share FacebookLinkedinTwitter Orhan Cam | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Common Scenarios Triggering False Claims Act Violations, Part 3: Claims and Investigations Compliance NJ Biopharma Company Settles FCA/AKS Case for $5M+ Compliance Common Scenarios Triggering False Claims Act Violations, Part 2: Construction and Workforce Issues